title: Management of relapsed multiple myeloma: recommendations of the International Myeloma Working Group.
abstract: The prognosis for patients multiple myeloma (MM) has improved substantially over the past decade with the development of new, more effective chemotherapeutic agents and regimens that possess a high level of anti-tumor activity. In spite of this important progress, however, nearly all MM patients ultimately relapse, even those who experience a complete response to initial therapy. Management of relapsed MM thus represents a vital aspect of the overall care for patients with MM and a critical area of ongoing scientific and clinical research. This comprehensive manuscript from the International Myeloma Working Group provides detailed recommendations on management of relapsed disease, with sections dedicated to diagnostic evaluation, determinants of therapy, and general approach to patients with specific disease characteristics. In addition, the manuscript provides a summary of evidence from clinical trials that have significantly impacted the field, including those evaluating conventional dose therapies, as well as both autologous and allogeneic stem cell transplantation. Specific recommendations are offered for management of first and second relapse, relapsed and refractory disease, and both autologous and allogeneic transplant. Finally, perspective is provided regarding new agents and promising directions in management of relapsed MM.
authors.affiliation: Dana-Farber Cancer Institute, Boston, MA, USA.
authors.forename: J
authors.initials: J
authors.lastname: Laubach
authors.affiliation: Hôpital Saint Antoine, Paris, France.
authors.forename: L
authors.initials: L
authors.lastname: Garderet
authors.affiliation: University of California San Francisco, San Francisco, CA, USA.
authors.forename: A
authors.initials: A
authors.lastname: Mahindra
authors.affiliation: Karolinska Institutet, Center for Hematology, Karolinska University Hospital Huddinge, Stockholm, Sweden.
authors.forename: G
authors.initials: G
authors.lastname: Gahrton
authors.affiliation: Department of Hematology, CHU Liège, Belgium.
authors.forename: J
authors.initials: J
authors.lastname: Caers
authors.affiliation: Memorial Hospital, Hematology Department, Istanbul, Turkey.
authors.forename: O
authors.initials: O
authors.lastname: Sezer
authors.affiliation: Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
authors.forename: P
authors.initials: P
authors.lastname: Voorhees
authors.affiliation: Maladies du sang, hôpital Huriez, CHRU, Lille, France.
authors.forename: X
authors.initials: X
authors.lastname: Leleu
authors.affiliation: Aalborg University Hospital, Aalborg, Denmark.
authors.forename: H E
authors.initials: HE
authors.lastname: Johnsen
authors.affiliation: King's College Hospital, London, UK.
authors.forename: M
authors.initials: M
authors.lastname: Streetly
authors.affiliation: Jagiellonian University Medical College, Kraków, Poland.
authors.forename: A
authors.initials: A
authors.lastname: Jurczyszyn
authors.affiliation: Wilhelminen Cancer Research Institute, Wilhelminenspital, Vienna, Austria.
authors.forename: H
authors.initials: H
authors.lastname: Ludwig
authors.affiliation: Sahlgrenska University Hospital, Gothenburg, Sweden.
authors.forename: U-H
authors.initials: UH
authors.lastname: Mellqvist
authors.affiliation: Cancer Science Institute, National University of Singapore, Singapore, Republic of Singapore.
authors.forename: W-J
authors.initials: WJ
authors.lastname: Chng
authors.affiliation: University of Alberta and Cross Cancer Institute, Edmonton, Canada.
authors.forename: L
authors.initials: L
authors.lastname: Pilarski
authors.affiliation: Department of Internal Medicine II, Division of Hematology, University Hospital of Würzburg, Würzburg, Germany.
authors.forename: H
authors.initials: H
authors.lastname: Einsele
authors.affiliation: The Myeloma and Lymphoma Center, Changzheng Hospital, The Second Military Medical University, Shanghai, China.
authors.forename: J
authors.initials: J
authors.lastname: Hou
authors.affiliation: Skano University Hospital, Malmo, Sweden.
authors.forename: I
authors.initials: I
authors.lastname: Turesson
authors.affiliation: "Seràgnoli" Institute of Hematology, Bologna University School of Medicine, Bologna, Italy.
authors.forename: E
authors.initials: E
authors.lastname: Zamagni
authors.affiliation: Department of Medicine, Queen Mary Hospital, Hong Kong, China.
authors.forename: C S
authors.initials: CS
authors.lastname: Chim
authors.affiliation: NYU Comprehensive Cancer Center, New York, NY, USA.
authors.forename: A
authors.initials: A
authors.lastname: Mazumder
authors.affiliation: Sahlgrenska University Hospital, Gothenburg, Sweden.
authors.forename: J
authors.initials: J
authors.lastname: Westin
authors.affiliation: Peking University People's Hospital, Beijing, China.
authors.forename: J
authors.initials: J
authors.lastname: Lu
authors.affiliation: Saint John Regional Hospital and Dalhousie University, Saint John, NB.
authors.forename: T
authors.initials: T
authors.lastname: Reiman
authors.affiliation: Karolinska Institutet, Center for Hematology, Karolinska University Hospital Huddinge, Stockholm, Sweden.
authors.forename: S
authors.initials: S
authors.lastname: Kristinsson
authors.affiliation: Royal Prince Alfred Hospital, Camperdown, Australia.
authors.forename: D
authors.initials: D
authors.lastname: Joshua
authors.affiliation: Hématologie clinique, hôpital Purpan, Toulouse, France.
authors.forename: M
authors.initials: M
authors.lastname: Roussel
authors.affiliation: National Institute for cellular Biotechnology, Dublin City University, Dublin, Ireland.
authors.forename: P
authors.initials: P
authors.lastname: O'Gorman
authors.affiliation: National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
authors.forename: E
authors.initials: E
authors.lastname: Terpos
authors.affiliation: Blood and Marrow Transplant Program, Roswell Park Cancer Institute, Buffalo, NY, USA.
authors.forename: P
authors.initials: P
authors.lastname: McCarthy
authors.affiliation: National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
authors.forename: M
authors.initials: M
authors.lastname: Dimopoulos
authors.affiliation: University Hospital Hotel-Dieu, Nantes, France.
authors.forename: P
authors.initials: P
authors.lastname: Moreau
authors.affiliation: Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
authors.forename: R Z
authors.initials: RZ
authors.lastname: Orlowski
authors.affiliation: Centro de Investigación Médica Aplicada, University of Navarra, Clínica Universidad de Navarra, Pamplona, Spain.
authors.forename: J S
authors.initials: JS
authors.lastname: Miguel
authors.affiliation: Dana-Farber Cancer Institute, Boston, MA, USA.
authors.forename: K C
authors.initials: KC
authors.lastname: Anderson
authors.affiliation: Department of Molecular Biotechnologies and Health Sciences, University of Torino, Torino, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Palumbo
authors.affiliation: Mayo Clinic, Rochester, MN, USA.
authors.forename: S
authors.initials: S
authors.lastname: Kumar
authors.affiliation: Mayo Clinic, Rochester, MN, USA.
authors.forename: V
authors.initials: V
authors.lastname: Rajkumar
authors.affiliation: Cedars-Sinai Outpatient Cancer Center, Los Angeles, CA, USA.
authors.forename: B
authors.initials: B
authors.lastname: Durie
authors.affiliation: Dana-Farber Cancer Institute, Boston, MA, USA.
authors.forename: P G
authors.initials: PG
authors.lastname: Richardson
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D019468:Disease Management; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods; D006801:Humans; D009101:Multiple Myeloma / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology / Q000628:therapy; D017410:Practice Guidelines as Topic; D012008:Recurrence; D016879:Salvage Therapy / Q000379:methods
chemical_list: D000970:Antineoplastic Agents